## NORIHIRO WATANABE

| | Title| Assistant Professor  
---|---  
Institution| Baylor College of Medicine  
Department| Department of Medicine  
Address| 1102 BATES  
Houston, TX 77030  
  
Email|
![](https://profiles.viictr.org/profile/modules/CustomViewPersonGeneralInfo/EmailHandler.ashx?msg=OLwx9WTJIYnVRIzgrn7GPw%3d%3d&rnd=70d27341-6450-4528-9142-9e91e9f154b4)  
vCard| [Download
vCard](https://profiles.viictr.org/profile/modules/CustomViewPersonGeneralInfo/vcard.aspx?subject=3009961)  
  

Other Positions| Title| Assistant Professor  
---|---  
Institution| Baylor College of Medicine  
Department| Center for Cell & Gene Therapy  
Division| Center for Cell & Gene Therapy  
  
  
  
  
![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
Bibliographic  

![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
selected publications

Publications listed below are automatically derived from MEDLINE/PubMed and
other sources, which might result in incorrect or missing publications.
Faculty can
[login](https://profiles.viictr.org/loginOptions.aspx?pin=send&method=login&edit=true)
to make corrections and additions.

Newest | Oldest | Most Cited | Most Discussed | Timeline | Field Summary | Plain Text

PMC Citations indicate the number of times the publication was cited by
articles in PubMed Central, and the Altmetric score represents citations in
news articles and social media. (Note that publications are often cited in
additional ways that are not shown here.) Fields are based on how the National
Library of Medicine (NLM) classifies the publication's journal and might not
represent the specific topic of the publication. Translation tags are based on
the publication type and the MeSH terms NLM assigns to the publication. Some
publications (especially newer ones and publications not in PubMed) might not
yet be assigned Field or Translation tags.) Click a Field or Translation tag
to filter the publications.

  1. Leung WK, Torres Chavez AG, French-Kim M, [Shafer P](https://profiles.viictr.org/profile/24845191), Mamonkin M, Hill LC, Kuvalekar M, Velazquez Y, Watanabe A, Watanabe N, Hoyos V, Lulla PD, [Leen AM](https://profiles.viictr.org/profile/268626), Leung WK, Torres Chavez AG, French-Kim M, Shafer P, [Mamonkin M](https://profiles.viictr.org/profile/1826306), Hill LC, Kuvalekar M, Velazquez Y, Watanabe A, **Watanabe N** , [Hoyos V](https://profiles.viictr.org/profile/23479202), [Lulla P](https://profiles.viictr.org/profile/3010220), Leen AM. Targeting IDH2R140Q and other neoantigens in acute myeloid leukemia. Blood. 2024 Apr 25; 143(17):1726-1737. PMID: [38241630](//www.ncbi.nlm.nih.gov/pubmed/38241630); PMCID: [PMC11103096](//www.ncbi.nlm.nih.gov/pmc/articles/PMC11103096).

Citations:  Fields:

Hem Hematology

  2. Mo F, Tsai CT, Zheng R, Cheng C, [Heslop HE](https://profiles.viictr.org/profile/269811), [Brenner MK](https://profiles.viictr.org/profile/268200), [Mamonkin M](https://profiles.viictr.org/profile/1826306), **Watanabe N**. Human platelet lysate enhances in vivo activity of CAR-Vd2 T cells by reducing cellular senescence and apoptosis. Cytotherapy. 2024 Mar 12. PMID: [38506769](//www.ncbi.nlm.nih.gov/pubmed/38506769).

Citations:  Fields:

Cel Cell BiologyThe Therapeutics

  3. Mo F, **Watanabe N** , Omdahl KI, [Burkhardt PM](https://profiles.viictr.org/profile/31454204), [Ding X](https://profiles.viictr.org/profile/17411454), Hayase E, Panoskaltsis-Mortari A, Jenq RR, [Heslop HE](https://profiles.viictr.org/profile/269811), Kean LS, [Brenner MK](https://profiles.viictr.org/profile/268200), Tkachev V, [Mamonkin M](https://profiles.viictr.org/profile/1826306). Engineering T cells to suppress acute GVHD and?leukemia relapse after allogeneic hematopoietic stem cell transplantation. Blood. 2023 03 09; 141(10):1194-1208. PMID: [36044667](//www.ncbi.nlm.nih.gov/pubmed/36044667); PMCID: [PMC10023730](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10023730).

Citations:

  4. [McKenna MK](https://profiles.viictr.org/profile/23496083), Ozcan A, Brenner D, **Watanabe N** , Legendre M, Thomas DG, Ashwood C, Cummings RD, Bonifant C, Markovitz DM, [Brenner MK](https://profiles.viictr.org/profile/268200). Novel banana lectin CAR-T cells to target pancreatic tumors and tumor-associated stroma. J Immunother Cancer. 2023 01; 11(1). PMID: [36653070](//www.ncbi.nlm.nih.gov/pubmed/36653070); PMCID: [PMC9853244](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9853244).

Citations:  Fields:

Neo NeoplasmsThe Therapeutics

Translation:HumansAnimalsCells

  5. **Watanabe N** , Mo F, Zheng R, Ma R, Bray VC, [van Leeuwen DG](https://profiles.viictr.org/profile/31189489), Sritabal-Ramirez J, Hu H, Wang S, Mehta B, Srinivasan M, [Scherer LD](https://profiles.viictr.org/profile/22016570), Zhang H, Thakkar SG, Hill LC, [Heslop HE](https://profiles.viictr.org/profile/269811), Cheng C, [Brenner MK](https://profiles.viictr.org/profile/268200), [Mamonkin M](https://profiles.viictr.org/profile/1826306). Feasibility and preclinical efficacy of CD7-unedited CD7 CAR T?cells for T?cell malignancies. Mol Ther. 2023 01 04; 31(1):24-34. PMID: [36086817](//www.ncbi.nlm.nih.gov/pubmed/36086817); PMCID: [PMC9840107](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9840107).

Citations:

  6. **Watanabe N** , Mo F, [McKenna MK](https://profiles.viictr.org/profile/23496083). Impact of Manufacturing Procedures on CAR T Cell Functionality. Front Immunol. 2022; 13:876339. PMID: [35493513](//www.ncbi.nlm.nih.gov/pubmed/35493513); PMCID: [PMC9043864](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9043864).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/35493513/citedby/) Fields:

All Allergy and Immunology

Translation:HumansCells

  7. Atilla PA, [McKenna MK](https://profiles.viictr.org/profile/23496083), **Watanabe N** , [Mamonkin M](https://profiles.viictr.org/profile/1826306), [Brenner MK](https://profiles.viictr.org/profile/268200), Atilla E. Combinatorial antigen targeting strategies for acute leukemia: application in myeloid malignancy. Cytotherapy. 2022 03; 24(3):282-290. PMID: [34955406](//www.ncbi.nlm.nih.gov/pubmed/34955406); PMCID: [PMC8950815](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8950815).

Citations:  Fields:

Cel Cell BiologyThe Therapeutics

Translation:AnimalsCellsCTClinical Trials

  8. Nalawade SA, [Shafer P](https://profiles.viictr.org/profile/24845191), Bajgain P, [McKenna MK](https://profiles.viictr.org/profile/23496083), Ali A, Kelly L, Joubert J, [Gottschalk S](https://profiles.viictr.org/profile/270181), **Watanabe N** , [Leen A](https://profiles.viictr.org/profile/268626), [Parihar R](https://profiles.viictr.org/profile/3009684), Vera Valdes JF, [Hoyos V](https://profiles.viictr.org/profile/23479202). Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer. J Immunother Cancer. 2021 11; 9(11). PMID: [34815355](//www.ncbi.nlm.nih.gov/pubmed/34815355); PMCID: [PMC8611441](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8611441).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/34815355/citedby/) Fields:

Neo NeoplasmsThe Therapeutics

Translation:HumansAnimalsCells

  9. **Watanabe N** , [McKenna MK](https://profiles.viictr.org/profile/23496083). Generation of CAR T-cells using ?-retroviral vector. Methods Cell Biol. 2022; 167:171-183. PMID: [35152995](//www.ncbi.nlm.nih.gov/pubmed/35152995); PMCID: [PMC8917789](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8917789).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/35152995/citedby/) Fields:

Cel Cell Biology

Translation:Cells

  10. **Watanabe N** , [Mamonkin M](https://profiles.viictr.org/profile/1826306). Off-the-Shelf Chimeric Antigen Receptor T Cells: How Do We Get There? Cancer J. 2021 Mar-Apr 01; 27(2):176-181. PMID: [33750078](//www.ncbi.nlm.nih.gov/pubmed/33750078); PMCID: [PMC8118392](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8118392).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33750078/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  11. **Watanabe N** , [McKenna MK](https://profiles.viictr.org/profile/23496083), [Rosewell Shaw A](https://profiles.viictr.org/profile/1826695), [Suzuki M](https://profiles.viictr.org/profile/265870). Clinical CAR-T Cell and Oncolytic Virotherapy for Cancer Treatment. Mol Ther. 2021 02 03; 29(2):505-520. PMID: [33130314](//www.ncbi.nlm.nih.gov/pubmed/33130314); PMCID: [PMC7854303](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7854303).

Citations:
[8](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33130314/citedby/) Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansCells

  12. Ataca Atilla P, [McKenna MK](https://profiles.viictr.org/profile/23496083), Tashiro H, Srinivasan M, Mo F, **Watanabe N** , Simons BW, McLean Stevens A, [Redell MS](https://profiles.viictr.org/profile/269414), [Heslop HE](https://profiles.viictr.org/profile/269811), [Mamonkin M](https://profiles.viictr.org/profile/1826306), [Brenner MK](https://profiles.viictr.org/profile/268200), Atilla E. Modulating TNFa activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemia. J Immunother Cancer. 2020 09; 8(2). PMID: [32938629](//www.ncbi.nlm.nih.gov/pubmed/32938629); PMCID: [PMC7497527](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7497527).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32938629/citedby/) Fields:

Neo NeoplasmsThe Therapeutics

Translation:HumansAnimalsCells

  13. Mo F, **Watanabe N** , [McKenna MK](https://profiles.viictr.org/profile/23496083), Hicks MJ, Srinivasan M, Gomes-Silva D, Atilla E, Smith T, Ataca Atilla P, Ma R, [Quach D](https://profiles.viictr.org/profile/3010661), [Heslop HE](https://profiles.viictr.org/profile/269811), [Brenner MK](https://profiles.viictr.org/profile/268200), [Mamonkin M](https://profiles.viictr.org/profile/1826306). Engineered off-the-shelf therapeutic T cells resist host immune rejection. Nat Biotechnol. 2021 01; 39(1):56-63. PMID: [32661440](//www.ncbi.nlm.nih.gov/pubmed/32661440); PMCID: [PMC7854790](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7854790).

Citations:
[26](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32661440/citedby/) Fields:

Bio Biotechnology

Translation:HumansAnimalsCells

  14. Leung WK, Workineh A, Mukhi S, Tzannou I, Brenner D, **Watanabe N** , [Leen AM](https://profiles.viictr.org/profile/268626), [Lulla P](https://profiles.viictr.org/profile/3010220). Evaluation of cyclin A1-specific T cells as a potential treatment for acute myeloid leukemia. Blood Adv. 2020 Jan 28; 4(2):387-397. PMID: [31985805](//www.ncbi.nlm.nih.gov/pubmed/31985805); PMCID: [PMC6988407](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6988407).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31985805/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  15. Torres Chavez A, [McKenna MK](https://profiles.viictr.org/profile/23496083), Canestrari E, Dann CT, [Ramos CA](https://profiles.viictr.org/profile/267038), [Lulla P](https://profiles.viictr.org/profile/3010220), [Leen AM](https://profiles.viictr.org/profile/268626), Vera JF, **Watanabe N**. Expanding CAR T cells in human platelet lysate renders T cells with in vivo longevity. J Immunother Cancer. 2019 11 28; 7(1):330. PMID: [31779709](//www.ncbi.nlm.nih.gov/pubmed/31779709); PMCID: [PMC6883585](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6883585).

Citations:
[8](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31779709/citedby/) Fields:

Neo NeoplasmsThe Therapeutics

Translation:HumansAnimalsCells

  16. Sukumaran S, **Watanabe N** , Bajgain P, Raja K, Mohammed S, [Fisher WE](https://profiles.viictr.org/profile/267699), [Brenner MK](https://profiles.viictr.org/profile/268200), [Leen AM](https://profiles.viictr.org/profile/268626), Vera JF. Enhancing the Potency and Specificity of Engineered T Cells for Cancer Treatment. Cancer Discov. 2018 08; 8(8):972-987. PMID: [29880586](//www.ncbi.nlm.nih.gov/pubmed/29880586); PMCID: [PMC6428579](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6428579).

Citations:
[44](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29880586/citedby/) Fields:

Neo Neoplasms

Translation:HumansAnimalsCells

  17. Bajgain P, Tawinwung S, D'Elia L, Sukumaran S, **Watanabe N** , [Hoyos V](https://profiles.viictr.org/profile/23479202), [Lulla P](https://profiles.viictr.org/profile/3010220), [Brenner MK](https://profiles.viictr.org/profile/268200), [Leen AM](https://profiles.viictr.org/profile/268626), Vera JF. CAR T cell therapy for breast cancer: harnessing the tumor milieu to drive T cell activation. J Immunother Cancer. 2018 05 10; 6(1):34. PMID: [29747685](//www.ncbi.nlm.nih.gov/pubmed/29747685); PMCID: [PMC5944113](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5944113).

Citations:
[39](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29747685/citedby/) Fields:

Neo NeoplasmsThe Therapeutics

Translation:Humans

  18. [Rosewell Shaw A](https://profiles.viictr.org/profile/1826695), Porter CE, **Watanabe N** , Tanoue K, Sikora A, [Gottschalk S](https://profiles.viictr.org/profile/270181), [Brenner MK](https://profiles.viictr.org/profile/268200), [Suzuki M](https://profiles.viictr.org/profile/265870). Adenovirotherapy Delivering Cytokine and Checkpoint Inhibitor Augments CAR T Cells against Metastatic Head and Neck Cancer. Mol Ther. 2017 11 01; 25(11):2440-2451. PMID: [28974431](//www.ncbi.nlm.nih.gov/pubmed/28974431); PMCID: [PMC5675597](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5675597).

Citations:
[77](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28974431/citedby/) Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansAnimalsCells

  19. Tanoue K, [Rosewell Shaw A](https://profiles.viictr.org/profile/1826695), **Watanabe N** , Porter C, Rana B, [Gottschalk S](https://profiles.viictr.org/profile/270181), [Brenner M](https://profiles.viictr.org/profile/268200), [Suzuki M](https://profiles.viictr.org/profile/265870). Armed Oncolytic Adenovirus-Expressing PD-L1 Mini-Body Enhances Antitumor Effects of Chimeric Antigen Receptor T Cells in Solid Tumors. Cancer Res. 2017 04 15; 77(8):2040-2051. PMID: [28235763](//www.ncbi.nlm.nih.gov/pubmed/28235763); PMCID: [PMC5392365](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5392365).

Citations:
[97](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28235763/citedby/) Fields:

Neo Neoplasms

Translation:HumansAnimalsCells

  20. Mohammed S, Sukumaran S, Bajgain P, **Watanabe N** , [Heslop HE](https://profiles.viictr.org/profile/269811), [Rooney CM](https://profiles.viictr.org/profile/268355), [Brenner MK](https://profiles.viictr.org/profile/268200), [Fisher WE](https://profiles.viictr.org/profile/267699), [Leen AM](https://profiles.viictr.org/profile/268626), Vera JF. Improving Chimeric Antigen Receptor-Modified T Cell Function by Reversing the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer. Mol Ther. 2017 01 04; 25(1):249-258. PMID: [28129119](//www.ncbi.nlm.nih.gov/pubmed/28129119); PMCID: [PMC5363304](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5363304).

Citations:
[112](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28129119/citedby/)
Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansAnimalsCells

  21. **Watanabe N** , Bajgain P, Sukumaran S, Ansari S, [Heslop HE](https://profiles.viictr.org/profile/269811), [Rooney CM](https://profiles.viictr.org/profile/268355), [Brenner MK](https://profiles.viictr.org/profile/268200), [Leen AM](https://profiles.viictr.org/profile/268626), Vera JF. Fine-tuning the CAR spacer improves T-cell potency. Oncoimmunology. 2016; 5(12):e1253656. PMID: [28180032](//www.ncbi.nlm.nih.gov/pubmed/28180032); PMCID: [PMC5214260](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5214260).

Citations:
[78](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28180032/citedby/) Fields:

All Allergy and ImmunologyNeo Neoplasms

  22. [Leen AM](https://profiles.viictr.org/profile/268626), Sukumaran S, **Watanabe N** , Mohammed S, Keirnan J, Yanagisawa R, Anurathapan U, Rendon D, [Heslop HE](https://profiles.viictr.org/profile/269811), [Rooney CM](https://profiles.viictr.org/profile/268355), [Brenner MK](https://profiles.viictr.org/profile/268200), Vera JF. Reversal of tumor immune inhibition using a chimeric cytokine receptor. Mol Ther. 2014 Jun; 22(6):1211-1220. PMID: [24732709](//www.ncbi.nlm.nih.gov/pubmed/24732709); PMCID: [PMC4048899](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4048899).

Citations:
[82](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24732709/citedby/) Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansAnimalsCells

This graph shows the total number of publications by year. To see the data as
text, click here.

![Bar chart showing 22 publications over 10 distinct years, with a maximum of
4 publications in 2020 and
2021](//chart.googleapis.com/chart?chs=595x100&chf=bg,s,ffffff|c,s,ffffff&chxt=x,y&chxl=0:|'94||'96||'98||'00||'02||'04||'06||'08||'10||'12||'14||'16||'18||'20||'22||'24|1:|0|4&cht=bvs&chd=t:0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25,0,25,75,50,25,100,100,50,50,50&chdl=Publications&chco=80B1D3&chbh=10)

This graph shows the total number of publications by year. To return to the
graph, click here.

Year| Publications  
---|---  
2014| 1  
2016| 1  
2017| 3  
2018| 2  
2019| 1  
2020| 4  
2021| 4  
2022| 2  
2023| 2  
2024| 2  
  
This graph shows the number and percent of publications by field. Fields are
based on how the National Library of Medicine (NLM) classifies the
publications' journals and might not represent the specific topics of the
publications. Note that an individual publication can be assigned to more than
one field. As a result, the publication counts in this graph might add up to
more than the number of publications the person has written. To see the data
as text, click here.

This graph shows the number and percent of publications by field. Fields are
based on how the National Library of Medicine (NLM) classifies the
publications' journals and might not represent the specific topics of the
publications. Note that an individual publication can be assigned to more than
one field. As a result, the publication counts in this graph might add up to
more than the number of publications the person has written. To see the data
as text, click here.

Start with: newest oldest Include: line numbers double spacing all authors
publication IDs

WATANABE's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (111)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

Derived automatically from this person's publications.

  * [Receptors, Antigen, T-Cell](https://profiles.viictr.org/profile/244627)
  * [Immunotherapy, Adoptive](https://profiles.viictr.org/profile/250092)
  * [T-Lymphocytes](https://profiles.viictr.org/profile/263702)
  * [Oncolytic Virotherapy](https://profiles.viictr.org/profile/243865)
  * [Lymphocyte Activation](https://profiles.viictr.org/profile/249474)

[Explore](https://profiles.viictr.org/profile/3009961/198)

_

Co-Authors (22)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People in Profiles who have published with this person.

  * [MAMONKIN, MAKSIM](https://profiles.viictr.org/profile/1826306)
  * [MCKENNA, MARY](https://profiles.viictr.org/profile/23496083)
  * [BRENNER, MALCOLM](https://profiles.viictr.org/profile/268200)
  * [SUZUKI, MASATAKA](https://profiles.viictr.org/profile/265870)
  * [LEEN, ANN](https://profiles.viictr.org/profile/268626)

[Explore](https://profiles.viictr.org/profile/3009961/345)

_

Similar People (60)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People who share similar concepts with this person.

  * [GOTTSCHALK, STEPHEN](https://profiles.viictr.org/profile/270181)
  * [BRENNER, MALCOLM](https://profiles.viictr.org/profile/268200)
  * [HESLOP, HELEN](https://profiles.viictr.org/profile/269811)
  * [NEELAPU, SATTVA S](https://profiles.viictr.org/profile/12583042)
  * [ROONEY, CLIONA](https://profiles.viictr.org/profile/268355)

[Explore](https://profiles.viictr.org/profile/3009961/476)

_

Same Department [ ![Expand
Description](https://profiles.viictr.org/Framework/Images/info.png)
](JavaScript:toggleVisibility\('sdDescript'\);)

People who are also in this person's primary department.

  * [DAYAH, RAWAN](https://profiles.viictr.org/profile/41820492)
  * [GRANJA, DIEGO](https://profiles.viictr.org/profile/42062973)
  * [NELSON, ELIZABETH](https://profiles.viictr.org/profile/269730)
  * [THOMAS, RYAN](https://profiles.viictr.org/profile/29494207)
  * [VONG, LINDA](https://profiles.viictr.org/profile/35457297)

[Explore](https://profiles.viictr.org/search/default.aspx?searchtype=people&searchfor=&SearchRequest=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)

_

Physical Neighbors
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People whose addresses are nearby this person.

  * [DONOHUE, WILLIAM](https://profiles.viictr.org/profile/266739)
  * [HEINEN, ALLISON](https://profiles.viictr.org/profile/3009609)
  * [JONES, JAMES](https://profiles.viictr.org/profile/269666)
  * [KATHURIA, NAVNEET](https://profiles.viictr.org/profile/266151)
  * [WOODARD, LECHAUNCY](https://profiles.viictr.org/profile/266760)

_

